SAMHSA data on drug-related ER visits released
The Substance Abuse and Mental Health Services Administration(SAMHSA) unveiled findings from its new Drug Abuse Warning Network(DAWN) showing almost two million drug-related emergency departmentvisits in 2004. Of these, nearly 1.3 million ER visits wereassociated with drug misuse or abuse.
SAMHSA data on drug-related ER visits released
The Substance Abuse and Mental Health Services Administration (SAMHSA) unveiled findings from its new Drug Abuse Warning Network (DAWN) showing almost two million drug-related emergency department visits in 2004. Of these, nearly 1.3 million ER visits were associated with drug misuse or abuse. DAWN estimates that 495,732 ER visits in 2004 were related to nonmedical use of Rx and OTC pharmaceuticals. Over half of these visits involved more than one drug. Opiates and opioid analgesics (prescription pain relievers) were the most frequently abused pharmaceuticals; they were involved in nearly one-third of visits involving nonmedical use. The full report is available at http://dawninfo.samhsa.gov/.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
